# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA621082 | A | Area under the concentration vs time curve in hamster at 10 mg/kg oral dose | Cricetinae | 1 | organism-based format | Scientific Literature | ||
2. | ALA625104 | A | Compound was tested for in vivo bioavailability in hamsters | Cricetinae | 1 | organism-based format | Scientific Literature | ||
3. | ALA620563 | A | Oral bioavailability in hamster at 10 mg/kg oral dose | Cricetinae | 1 | organism-based format | Scientific Literature | ||
4. | ALA626038 | A | Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose | Cricetinae | 1 | organism-based format | Scientific Literature | ||
5. | ALA626048 | A | Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose. | Cricetinae | 2 | organism-based format | Scientific Literature | ||
6. | ALA622826 | A | Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose | Cricetinae | 1 | organism-based format | Scientific Literature | ||
7. | ALA622827 | A | Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose | Cricetinae | 1 | organism-based format | Scientific Literature | ||
8. | ALA624743 | A | Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma | Cricetinae | 2 | organism-based format | Scientific Literature | ||
9. | ALA622506 | A | Oral integrated area under the concentration vs time curve, for compound in hamster plasma | Cricetinae | 1 | organism-based format | Scientific Literature | ||
10. | ALA622507 | A | Oral integrated area under the concentration vs time curve, for compound in hamster plasma | Cricetinae | 1 | organism-based format | Scientific Literature | ||
11. | ALA625432 | A | Bioavailability was evaluated in hamster | Cricetinae | 1 | organism-based format | Scientific Literature | ||
12. | ALA876653 | A | Plasma clearance after iv administration at 3 mg/kg in hamster | Cricetinae | 1 | organism-based format | Scientific Literature | ||
13. | ALA622811 | A | Plasma clearance after iv administration at 4 mg/kg in hamster | Cricetinae | 1 | organism-based format | Scientific Literature | ||
14. | ALA635557 | A | Time of maximum concentration of compound in hamster plasma. | Cricetinae | 2 | organism-based format | Scientific Literature | ||
15. | ALA635034 | A | oral bioavailability in Hamsters | Cricetinae | 1 | organism-based format | Scientific Literature | ||
16. | ALA633559 | A | Tmax is the time of maximum concentration in hamster at 10 mg/kg oral dose | Cricetinae | 1 | organism-based format | Scientific Literature | ||
17. | ALA630769 | A | Time taken to reach maximum drug concentration in plasma of hamster at 40 mg/kg oral dose | Cricetinae | 2 | organism-based format | Scientific Literature | ||
18. | ALA635586 | A | Volume distribution after iv administration at 3 mg/kg in hamster | Cricetinae | 1 | organism-based format | Scientific Literature | ||
19. | ALA635587 | A | Volume distribution after iv administration at 4 mg/kg in hamster | Cricetinae | 1 | organism-based format | Scientific Literature | ||
20. | ALA629103 | A | Activity measured as 4-aminoazobenzene (AAB) transacetylation rate with partially purified hamster hepatic enzyme | Cricetinae | 10 | organism-based format | Scientific Literature |